Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Leenders

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Experimental Pathology|May 13, 1999
Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?W P Leenders
Biochemical and Biophysical Research Communications|November 30, 1994
Cloning and production of functional active recombinant hepatitis B virus surface antigen binding proteinW P Leenders, W C de Bruin
Journal of Hepatology|March 1, 1996
Species specificity for HBsAg binding protein endonexin IIW C de Bruin, W P Leenders, H Moshage, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: putative external and internal receptors for infection and secretion of hepatitis B virusW P Leenders, H L Glansbeek, W C de Bruin, et al.
The Journal of General Virology|April 1, 1995
Hepatitis B virus: specific binding and internalization of small HBsAg by human hepatocytesW C de Bruin, K Hertogs, W P Leenders, et al.
Mechanisms of Development|December 10, 1997
Synergism between temporally distinct growth factors: bFGF, insulin and lens cell differentiationW P Leenders, S T van Genesen, J G Schoenmakers, et al.
Virology|December 1, 1993
Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope proteinK Hertogs, W P Leenders, E Depla, et al.
Growth Factors (Chur, Switzerland)|January 1, 1997
Mutants of basic fibroblast growth factor identify different cellular response programsW P Leenders, V W van Hinsbergh, S T van Genesen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Experimental Pathology|May 13, 1999
Targetting VEGF in anti-angiogenic and anti-tumour therapy: where are we now?W P Leenders
Biochemical and Biophysical Research Communications|November 30, 1994
Cloning and production of functional active recombinant hepatitis B virus surface antigen binding proteinW P Leenders, W C de Bruin
Journal of Hepatology|March 1, 1996
Species specificity for HBsAg binding protein endonexin IIW C de Bruin, W P Leenders, H Moshage, et al.
Hepatology (Baltimore, Md.)|July 1, 1990
Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: putative external and internal receptors for infection and secretion of hepatitis B virusW P Leenders, H L Glansbeek, W C de Bruin, et al.
The Journal of General Virology|April 1, 1995
Hepatitis B virus: specific binding and internalization of small HBsAg by human hepatocytesW C de Bruin, K Hertogs, W P Leenders, et al.
Mechanisms of Development|December 10, 1997
Synergism between temporally distinct growth factors: bFGF, insulin and lens cell differentiationW P Leenders, S T van Genesen, J G Schoenmakers, et al.
Virology|December 1, 1993
Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope proteinK Hertogs, W P Leenders, E Depla, et al.
Growth Factors (Chur, Switzerland)|January 1, 1997
Mutants of basic fibroblast growth factor identify different cellular response programsW P Leenders, V W van Hinsbergh, S T van Genesen, et al.
Pageof 1